BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/27/21 Provention Bio (PRVB) Teplizumab for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
5/26/21 Pacira BioSciences (PCRX) Exparel for Postsurgical Pain Subscribers Only Subscribers Only Subscribers Only
5/25/21 AB Science (AB) Masitinib for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
5/25/21 Oncopeptides AB (ONCO) Pepaxto for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
5/25/21 Provention Bio (PRVB) Teplizumab for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
05/28/21 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/30/21 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/30/21 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Results
05/30/21 Subscribers Only Subscribers Only Regulatory - CHMP (European Panel) Results
Back to the top Back to the top